Profile data is unavailable for this security.
About the company
El En SpA is an Italy-based company primarily engaged in the production of laser systems. It controls a group of companies active in the manufacture, research, development, distribution and sale of laser equipment.The Company's range of products includes laser systems for dermatology, surgery, cosmetics, physiotherapy, dentistry and gynaecology, laser systems for cutting, marking and welding of metals, wood, plastic and glass; decoration of leather and fabrics, conservative restoration of works of art. The Company also offers accessories, after-sale services and consulting in the related areas.
- Revenue in EUR (TTM)659.63m
- Net income in EUR49.76m
- Incorporated--
- Employees2.03k
- LocationEl En SpAVia Baldanzese, 17CALENZANO 50041ItalyITA
- Phone+39 558826807
- Fax+39 558832884
- Websitehttps://elengroup.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CellaVision AB | 63.79m | 13.00m | 499.51m | 228.00 | 38.43 | 7.52 | 30.08 | 7.83 | 6.30 | 6.30 | 30.91 | 32.19 | 0.7849 | 1.91 | 7.26 | 3,233,162.00 | 15.99 | 15.30 | 18.45 | 18.24 | 66.99 | 69.03 | 20.38 | 19.98 | 2.15 | 1,358.86 | 0.044 | 110.18 | 5.94 | 13.17 | 10.12 | 8.00 | 30.45 | 8.45 |
| Surgical Science Sweden AB | 72.54m | 17.11m | 507.81m | 265.00 | 29.68 | 1.28 | 22.98 | 7.00 | 3.87 | 3.87 | 16.43 | 90.02 | 0.1695 | 1.49 | 7.35 | 3,224,027.00 | 4.00 | 4.49 | 4.26 | 4.78 | 68.51 | 70.06 | 23.59 | 23.75 | 3.46 | -- | 0.00 | 0.00 | 10.01 | 68.14 | 24.47 | -- | 38.57 | -- |
| Advanced Medical Solutions Group plc | 158.34m | 13.45m | 593.12m | 1.50k | 44.21 | 2.02 | 21.86 | 3.75 | 0.051 | 0.051 | 0.6011 | 1.12 | 0.3977 | 1.70 | 4.91 | 154,244.70 | 3.38 | 6.54 | 3.64 | 7.06 | 54.45 | 56.75 | 8.49 | 14.82 | 6.80 | -- | 0.2702 | 25.85 | 1.51 | 4.23 | -22.14 | -6.71 | 15.66 | 12.32 |
| Paul Hartmann AG | 2.38bn | 59.53m | 714.48m | 10.05k | 11.93 | 0.6284 | 4.25 | 0.2998 | 16.76 | 16.76 | 671.22 | 318.25 | 1.18 | 1.99 | 5.45 | 234,407.10 | 3.19 | 3.87 | 4.19 | 5.34 | 58.00 | 56.71 | 2.70 | 2.98 | 1.31 | 7.68 | 0.2082 | 42.75 | 1.80 | 2.12 | -21.37 | -18.49 | 5.95 | 2.71 |
| Revenio Group Oyj | 102.08m | 19.01m | 775.89m | 230.00 | 40.37 | 7.64 | 31.99 | 7.60 | 0.7204 | 0.7204 | 3.86 | 3.81 | 0.7834 | 4.93 | 8.17 | 472,574.10 | 14.67 | 14.33 | 17.09 | 17.90 | 49.29 | 50.73 | 18.72 | 21.13 | 1.51 | 34.57 | 0.1276 | 55.81 | -0.4125 | 25.80 | -12.15 | 18.72 | 17.67 | 6.30 |
| Medartis Holding AG | 234.72m | 4.30m | 780.84m | 829.00 | 174.55 | 2.69 | 28.64 | 3.33 | 0.3088 | 0.3088 | 17.04 | 20.07 | 0.5377 | 0.5674 | 4.96 | 265,720.50 | 0.9845 | 0.1919 | 1.13 | 0.2153 | 80.53 | 82.33 | 1.83 | 0.3542 | 3.15 | 4.03 | 0.3227 | 0.00 | 15.96 | 11.81 | 110.70 | -31.82 | 5.37 | -- |
| Arjo AB (publ) | 967.68m | 44.22m | 781.67m | 6.85k | 18.94 | 1.23 | 6.03 | 0.8078 | 1.88 | 1.88 | 41.05 | 28.87 | 0.7149 | 4.54 | 6.78 | 1,644,896.00 | 3.26 | 3.55 | 4.62 | 5.55 | 43.64 | 44.01 | 4.56 | 5.41 | 0.626 | 3.97 | 0.4073 | 43.01 | 10.03 | 5.97 | 6.90 | 10.15 | -8.89 | 10.35 |
| Draegerwerk AG & Co KGaA | 3.35bn | 113.44m | 821.34m | 16.56k | 6.98 | 0.552 | 3.18 | 0.2454 | 6.05 | 6.05 | 178.45 | 76.45 | 1.11 | 2.47 | 4.97 | 205,014.40 | 3.80 | 3.26 | 5.61 | 4.87 | 43.51 | 44.16 | 3.41 | 3.05 | 1.10 | 6.83 | 0.1704 | 11.38 | 10.78 | 5.39 | 271.05 | 33.87 | 2.64 | 55.73 |
| El En SpA | 659.63m | 49.76m | 952.91m | 2.03k | 19.12 | 2.65 | 15.21 | 1.44 | 0.6223 | 0.6223 | 8.25 | 4.49 | 0.9141 | 1.77 | 3.69 | 316,823.50 | 7.02 | 7.43 | 12.89 | 13.52 | 40.03 | 38.83 | 7.68 | 7.63 | 1.19 | -- | 0.1845 | -- | 2.78 | 14.88 | -12.47 | 23.49 | -13.40 | -- |
| GVS SpA | 426.19m | 25.33m | 1.03bn | 4.39k | 40.42 | 2.88 | 14.74 | 2.42 | 0.1457 | 0.1457 | 2.44 | 2.05 | 0.4303 | 2.00 | 6.16 | 97,169.86 | 2.56 | 7.35 | 3.25 | 10.82 | 55.12 | 58.74 | 5.94 | 12.44 | 1.03 | 3.98 | 0.5461 | -- | 9.58 | 15.25 | -43.37 | -9.97 | 16.08 | -- |
| Biotage AB | 184.07m | 22.24m | 1.13bn | 675.00 | 50.94 | 3.44 | 29.88 | 6.15 | 3.21 | 3.21 | 26.56 | 47.60 | 0.4312 | 1.59 | 7.22 | 3,155,786.00 | 5.21 | 10.74 | 6.05 | 12.77 | 62.67 | 61.40 | 12.08 | 15.75 | 1.15 | 43.88 | 0.0616 | 40.11 | 19.54 | 15.50 | -8.21 | 7.97 | 14.05 | 1.30 |
| ChemoMetec A/S | 54.68m | 18.27m | 1.17bn | 173.00 | 63.97 | 15.42 | 56.62 | 21.38 | 7.83 | 7.83 | 23.44 | 32.48 | 0.6112 | 0.745 | 6.97 | 2,357,630.00 | 20.42 | 27.96 | 24.40 | 35.10 | 78.80 | 79.57 | 33.41 | 35.02 | 3.76 | -- | 0.0073 | 144.08 | -8.22 | 18.37 | -23.72 | 26.64 | 9.97 | -11.81 |
| Xvivo Perfusion AB | 64.96m | 17.68m | 1.26bn | 161.00 | 70.53 | 7.02 | 52.96 | 19.47 | 6.58 | 6.58 | 24.07 | 66.13 | 0.3325 | 1.14 | 4.67 | 4,691,194.00 | 9.05 | 1.24 | 9.68 | 1.33 | 74.41 | 73.14 | 27.21 | 4.76 | 4.23 | -- | 0.0117 | 0.00 | 43.88 | 26.04 | 398.29 | 48.57 | 21.35 | -- |
Data as of Nov 12 2024. Currency figures normalised to El En SpA's reporting currency: Euro EUR
20.28%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Van Lanschot Kempen Investment Management NVas of 29 Apr 2024 | 4.01m | 5.01% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 2.71m | 3.39% |
| Mediolanum Gestione Fondi SGRpAas of 28 Jun 2024 | 1.86m | 2.32% |
| The Vanguard Group, Inc.as of 02 Oct 2024 | 1.82m | 2.28% |
| Arca Fondi SGR SpAas of 30 Sep 2024 | 1.63m | 2.04% |
| Fideuram Asset Management SGR SpAas of 31 Oct 2024 | 1.13m | 1.42% |
| Praude Asset Management Ltd.as of 29 Feb 2024 | 951.10k | 1.19% |
| Allianz Global Investors GmbH (France)as of 31 Jul 2024 | 848.82k | 1.06% |
| KBC Asset Management NVas of 30 Jun 2024 | 678.03k | 0.85% |
| Goldman Sachs Asset Management BVas of 30 Jun 2024 | 586.71k | 0.73% |
More ▼
Data from 29 Feb 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
